Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03999177 · ClinicalTrials.gov registry record · NA

Pilot Usability and Feasibility Testing on Kinect-Enhanced Training System for Lymphatic Exercises

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT03999177 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03999177, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

Correct performance of therapeutic lymphatic exercises has the potential to relieve lymphedema symptoms and optimize limb volume and lymph fluid level, in turn to improve breast cancer survivors' quality of life and reduce the risk of lymphedema. Kinect-TOLF (Kinect-Enhanced The-Optimal-Lymph-Flow Training System) is an innovative intelligent Kinect-enhanced training system to teach patients to perform the lymphatic exercises correctly. The Kinect-TOLF training system is not a medical device but a computer/mobile and motion-sensor program that helps patients to perform the lymphatic exercises correctly. The Kinect system can automatically detect whether a user is performing the set of lymphatic exercises correctly in real time and provide instantaneous feedback to the user, thus enhancing patients' self-efficacy to perform the lymphatic exercises correctly. The goal of the proposed project is to evaluate the usability and feasibility of Kinect-TOLF.

Interventions

  • BEHAVIORAL Kinect-TOLF Training System

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2019-06-01
Est. Completion 2019-09-01
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT03999177

The ClinicalTrials.gov registry entry for NCT03999177 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Kinect-TOLF Training System is the first listed.

NCT03999177 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03999177 about?

NCT03999177 is a clinical study titled "Pilot Usability and Feasibility Testing on Kinect-Enhanced Training System for Lymphatic Exercises". Correct performance of therapeutic lymphatic exercises has the potential to relieve lymphedema symptoms and optimize limb volume and lymph fluid level, in turn to improve breast cancer survivors' quality of life and reduce the risk of lymphedema. Kinect-TOLF (Kinect-Enhanced The-Optimal-Lymph-Flow T...

What is the current status of trial NCT03999177?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2019-06-01. Estimated completion is 2019-09-01.

What interventions are being tested in trial NCT03999177?

The interventions under investigation include: Kinect-TOLF Training System (BEHAVIORAL).

Who is sponsoring clinical trial NCT03999177?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.